Antagonism of nicotinic receptors of rat chromaffin cells by N,N,N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: A patch clamp and ligand binding study

British Journal of Pharmacology

Volumn 129, Issue 8, 2000, Pages 1771-1779

  Di Angelantonio, Silvia ^a   Nistri, Andrea ^a   Moretti, Milena ^b   Clementi, Francesco ^b   Gotti, Cecilia ^b  

^a SISSA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

4 Oxystilbene; Chromaffin cell; Competitive antagonism; Epibatidine; Nicotine; Nicotinic receptor

Indexed keywords

ACETYLCHOLINE; ALPHA BUNGAROTOXIN; CHOLINERGIC RECEPTOR; CYSTINE; EPIBATIDINE; IODINE 125; N,N,N TRIMETHYL 1 (4 TRAMS STILBENOXY) 2 PROPYLAMMONIUM IODIDE; NICOTINE; NICOTINIC RECEPTOR; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CATTLE; CHICKEN; CHROMAFFIN CELL; CONTROLLED STUDY; DOSE RESPONSE; ELECTROPHYSIOLOGY; LIGAND BINDING; MEMBRANE; NERVOUS TISSUE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SPECIES DIFFERENCE;

EID: 0034000758     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703264     Document Type: Article

References (27)

1. ANDERSON, D.J. (1993). Molecular control of cell fate in the neural crest: the symphatoadrenal lineage. Annu. Rev. Neurosci., 16, 129-158.
2. BERTRAND, S., PATT, J.T., SPANG, J.S., WESTERA, G., SCHUBIGER, P.A. & BERTRAND, D. (1999). Neuronal nAChR stereoselectivity to non-natural epibatidine derivatives. FEBS Lett. 450, 273-279.
3. BRANDT. B.L., HAGIWARA, S., KIDOKORO, Y. & MIYAZAKI, S. (1976). Action potentials in the rat chromaffin cell and effects of ACh. J. Physiol., 263, 417-439.
4. CAMPOS-CARO, A., SMILLIE, F.I., DOMINGUEZ DEL TORO, E., ROVIRA, J.C., VICENTE-AGULLO, F., CHAPULI, J., JUIZ, J.M., SALA, F., BALLESTA, J.J. & CRIADO, M. (1997). Neuronal nicotinic ACh receptors on bovine chromaffin cells: cloning, expression and genomic organization of receptor subunits. J. Neurochem., 68, 488-497.
5. CAVALLINI, G., MANTEGAZZA, P., MASSARINI, E. & TOMMASINI, R. (1953). Sull'attivita' ganglioplegica di alcuni derivati alchilaminici dello stilbene e del difenile. Il Farmaco 6, 317-331.
6. CHANGEUX, J.P. & EDELSTEIN, S.J. (1998). Allosteric receptors after 30 years. Neuron, 21, 959-980.
7. 125I-IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J. Pharmacol. Exp. Therap., 282, 445-451.
8. GARCIA-GUZMAN, M., SALA, F., SALA, S., CAMPOS CARO, A., STUHMER, W., GUTIERREZ, L. & CRIADO, M. (1995). αBungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: molecular cloning, functional expression and alternative splicing of the α7 subunit. Eur. J. Neurosci., 7, 647-655.
9. GERZANICH, V., PENG, X., WANG, F., WELLS, G., ANAND, R., FLETCHER, S. & LINDSTROM, J. (1995). Comparative pharmacology of epibatidine: a polent agonist for neuronal nicotinic ACh receptors. Mol. Pharmacol., 48, 774-782.
10. 2+ in rat chromaffin cells in vitro. J. Neurosci., 19, 2945-2953.
11. GINIATULLIN, R., KHIROUG, L., TALANTOVA, M. & NISTRI, A. (1996). Fading and rebound of currents induced by ATP on PC12 cells. Br. J. Pharmacol., 119, 1045-1053.
12. GOTTI, C., BALESTRA, B., MORETTI, M., ROVATI, G.E., MAGGI, L., ROSSONT, G., BERTI, F., VILLA, L., PALLAVICINI, M. & CLEMENTI, F. (1998). 4-oxystilbene compounds are selective ligands for neuronal nicotinic αBungarotoxin receptors. Br. J. Pharmacol., 124, 1197-1206.
13. GOTTI, C., FORNASARI, D. & CLEMENTI, F. (1997). Human neuronal nicotinic ACh receptors. Prog. Neurobiol., 53, 199-237.
14. KHIROUG, L., GINIATULLIN, R., SOKOLOVA, E., TALANTOVA, M. & NISTRI, A. (1997). Imaging of intracellular calcium during desensitization of nicotinic acetylcholine receptors of rat chromaffin cells. Br. J. Pharmacol., 122, 1323-1332.
15. KHIROUG, L., SOKOLOVA, E., GINIATULLIN, R., AFZALOV, R. & NISTRI, A. (1998). Recovery from desensitization of neuronal nicotinic acetylcholine receptors of rat chromaffin cells is modulated by intracellular calcium through distinct second messengers. J. Neurosci., 18, 2458-2466.
16. LENA, C. & CHANGEUX, J-P. (1997). Pathological mutations of nicotinic receptors and nicotine-based therapies for brain disorders. Curr. Opin. Neurobiol., 7, 674-682.
17. LINDSTROM, J. (1997). Nicotinic acetylcholine receptors in health and disease. Mol. Neurobiol., 15, 193-222.
18. LOPEZ, M.G., MONTIEL, C., HERRERO, C.J., GARCIA-PALOMERO, E., MAYORGAS, I., HERNANDEZ-GUIJO, J.M., VILLAROYA, M., OLIVARES, R., GANDIA, L., MCINTOSH, J.M., OLIVERA, B.M. & GARCIA, A.G. (1998). Unmasking the functions of the chromaffin cell α7 nicotinic receptor by using short pulses of acetylcholine and selective blockers. Proc. Natl. Acad. Sci. U.S.A., 95, 14184-14189.
19. MAGGI, L., PALMA, E., EUSEBI, F., MORETTI, M., BALESTRA, B., CLEMENTI, F. & GOTTI, C. (1999). Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick α7 nicotinic receptor. Br. J. Pharmacol., 126, 285-295.
20. MANTEGAZZA, P. & TOMMASINI, R. (1955). Central antinicotinic activity of 4-oxystilbene and 4-oxydiphenylethane derivatives. Arch. Int. Pharmacodyn., 4, 371-403.
21. NEHER, E. & STEINBACH, J.H. (1978). Local anaesthetics transiently block currents through single acetylcholine receptor channels. J. Physiol., 277, 153-176.
22. NOONEY, J.M., PETERS, J.A. & LAMBERT, J.J. (1992). A patch clamp study of the nicotinic acetylcholine receptor of bovine adreno-medullary chromaffin cells in culture. J. Physiol., 455, 503-527.
23. PARKER, M., BECK, A. & LUETJE, W. (1998). Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity. Mol. Pharmacol., 54, 1132-1139.
24. ROLE, L.W. & BERG, K.D. (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron, 16, 1077-1085.
25. WILSON, S.P. & KIRSHNER, N. (1977). The acetylcholine receptor of the adrenal medulla. J. Neurochem., 28, 687-693.
26. XIAO, Y., MEYER, E.L., THOMPSON, J.M., SURIN, A., WROBLEWSKI, J. & KELLAR, K.J. (1998). Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol. Pharmacol., 54, 322-333.
27. 2+ permeation of stably transfected α3/β4 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol., 55, 970-981.